title: Results of Neodymium: YAG Laser Transscleral Cyclophotocoagulation for Postkeratoplasty Glaucoma.
abstract: Postkeratoplasty glaucoma is a significant cause of visual loss after penetrating keratoplasty. Surgery for postkeratoplasty glaucoma refractory to medical treatment has been difficult and carries with it a high risk of failure of the corneal graft. Nd:YAG laser transscleral cyclophotocoagulation (Nd:YAG CPC) was used to treat 19 patients with glaucoma refractory to medical therapy after penetrating keratoplasty. The glaucoma was controlled with Nd:YAG CPC in 13 of 19 patients (68%). The mean follow-up after the first Nd:YAG CPC treatment was 17.2 $pM 8.9 months. The mean follow-up after the last Nd:YAG CPC treatment was 14.1 $pM 8.1 months. Of 14 grafts that were clear before Nd:YAG CPC, two (14%) became edematous after treatment with Nd:YAG CPC. Five patients (26%) lost two or more lines of visual acuity. One vitreous hemorrhage occurred. Intraocular pressure elevations in the periop-erative period occurred infrequently. No patient developed persistent hypot-ony after Nd:YAG CPC. Postoperative inflammation and pain were minimal. Nd:YAG CPC appears to be a viable alternative for treatment of postkeratoplasty glaucoma refractory to medical treatment.
authors.affiliation: * University of Minnesota School of Medicine, Department of Ophthalmology, Minneapolis dagger Group Health, Inc., St. Paul, Minnesota, U.S.A.
authors.forename: D R
authors.initials: DR
authors.lastname: Hardten
authors.forename: J D
authors.initials: JD
authors.lastname: Brown
authors.forename: E J
authors.initials: EJ
authors.lastname: Holland